๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium

โœ Scribed by V. McGuire; S.K. Van Den Eeden; C.M. Tanner; F. Kamel; D.M. Umbach; K. Marder; R. Mayeux; B. Ritz; G.W. Ross; H. Petrovitch; B. Topol; R.A. Popat; S. Costello; A.D. Manthripragada; A. Southwick; R.M. Myers; L.M. Nelson


Book ID
119304124
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
199 KB
Volume
307
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Allelic association between the DRD2 Taq
โœ L. Grevle; C. Gรผzey; H. Hadidi; R. Brennersted; J. R. Idle; J. Aasly ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 50 KB ๐Ÿ‘ 3 views

Genes encoding proteins involved in dopaminergic transmission have been of special interest during the evaluation of candidate genes for Parkinson's disease (PD). The dopamine D2 receptor gene (DRD2) is located on chromosome 11 q22-q23, and several polymorphisms of the gene have been described. The

The DRD2 TaqIA polymorphism and demand o
โœ Sebastian Paus; Anne Grรผnewald; Christine Klein; Michael Knapp; Alexander Zimpri ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB ๐Ÿ‘ 1 views

## Abstract Previous studies have demonstrated that the __TaqIA__ polymorphism of the D2 dopamine receptor gene (__DRD__2) is associated with response to dopaminergic and antidopaminergic treatment in Parkinson's disease (PD) and schizophrenia, respectively. We tested whether the __TaqIA__ genotype